Practical biomedical application of mesoporous silica nanoparticles is limited by poor
particle dispersity and stability due to serious irreversible aggregation in biological media …

Since the first report of mesoporous silica nanoparticles in 2001, many efforts have been
made to develop them for biomedical applications. With the emergence of new designs and …

Since the first report in early 1990s, mesoporous silica nanoparticles (MSNs) have
progressively attracted the attention of scientists due to their potential applications in physic …

In this work, sub-50 nm pegylated mesoporous silica nanoparticles prepared with
hydrothermal treatment are shown to have long-term stability in various media at both room …

We report on the endocytosis and the time-dependent enhanced cytotoxicity of anticancer
platinum drugs when the drugs are combined with (or loaded into) one of the two most …

Highlights•Structural and geometrical features of mesoporous silica can benefit drug
delivery.•Coupled with therapeutic agents, targeting for a host of cancers is …

Silica thin films and nanoparticles prepared using sol–gel chemistry are derivatized with
active molecules to generate new functional materials. The mild conditions associated with …

Mesoporous silica nanoparticles (MSNs) are a promising material for drug delivery. In this
Full Paper, MSNs are first shown to be well tolerated, as demonstrated by serological …

This review details the recent advancements in the design of mesoporous silica
nanomaterials for controlled release drug, gene and neurotransmitter delivery applications …

Nanotechnology is an emerging area of research for the exploitation of various scientific
advancements for controlling material configuration at a reduced dimensional scale. With …